Next Article in Journal / Special Issue
Gene Sequence Based Clustering Assists in Dereplication of Pseudoalteromonas luteoviolacea Strains with Identical Inhibitory Activity and Antibiotic Production
Previous Article in Journal
Glycosides from Marine Sponges (Porifera, Demospongiae): Structures, Taxonomical Distribution, Biological Activities and Biological Roles
Previous Article in Special Issue
Microbial Regulation in Gorgonian Corals
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2012, 10(8), 1711-1728; doi:10.3390/md10081711

Evaluation of Pseudopteroxazole and Pseudopterosin Derivatives against Mycobacterium tuberculosis and Other Pathogens

1
Department of Chemistry and Department of Biomedical Sciences, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PEI C1A 4P3, Canada
2
Nautilus Biosciences Canada, Inc., Charlottetown, PEI C1A 4P3, Canada
*
Author to whom correspondence should be addressed.
Received: 12 June 2012 / Revised: 25 July 2012 / Accepted: 1 August 2012 / Published: 15 August 2012
(This article belongs to the Special Issue Marine Antibiotics)
View Full-Text   |   Download PDF [327 KB, uploaded 24 February 2015]   |  

Abstract

Pseudopterosins and pseudopteroxazole are intriguing marine natural products that possess notable antimicrobial activity with a commensurate lack of cytotoxicity. New semi-synthetic pseudopteroxazoles, pseudopteroquinoxalines and pseudopterosin congeners along with simple synthetic mimics of the terpene skeleton were synthesized. In order to build structure-activity relationships, a set of 29 new and previously reported compounds was assessed for in vitro antimicrobial and cytotoxic activities. A number of congeners exhibited antimicrobial activity against a range of Gram-positive bacteria including Mycobacterium tuberculosis H37Rv, with four displaying notable antitubercular activity against both replicating and non-replicating persistent forms of M. tuberculosis. One new semi-synthetic compound, 21-((1H-imidazol-5-yl)methyl)-pseudopteroxazole (7a), was more potent than the natural products pseudopterosin and pseudopteroxazole and exhibited equipotent activity against both replicating and non-replicating persistent forms of M. tuberculosis with a near absence of in vitro cytotoxicity. Pseudopteroxazole also exhibited activity against strains of M. tuberculosis H37Rv resistant to six clinically used antibiotics. View Full-Text
Keywords: pseudopteroxazoles; semi-synthesis; Mycobacterium tuberculosis; antibiotic-resistance pseudopteroxazoles; semi-synthesis; Mycobacterium tuberculosis; antibiotic-resistance
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

McCulloch, M.W.B.; Haltli, B.; Marchbank, D.H.; Kerr, R.G. Evaluation of Pseudopteroxazole and Pseudopterosin Derivatives against Mycobacterium tuberculosis and Other Pathogens. Mar. Drugs 2012, 10, 1711-1728.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top